Barclays’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-29,251
| Closed | -$20K | – | 4538 |
|
|
2023
Q1 | $20K | Sell |
29,251
-78,066
| -73% | -$53.4K | ﹤0.01% | 3998 |
|
|
2022
Q4 | $88K | Sell |
107,317
-310,448
| -74% | -$255K | ﹤0.01% | 3539 |
|
|
2022
Q3 | $434K | Sell |
417,765
-13,043
| -3% | -$13.6K | ﹤0.01% | 2674 |
|
|
2022
Q2 | $707K | Buy |
430,808
+325,689
| +310% | +$534K | ﹤0.01% | 2327 |
|
|
2022
Q1 | $310K | Buy |
105,119
+43,484
| +71% | +$128K | ﹤0.01% | 3082 |
|
|
2021
Q4 | $295K | Buy |
61,635
+36,797
| +148% | +$176K | ﹤0.01% | 2720 |
|
|
2021
Q3 | $189K | Sell |
24,838
-34,668
| -58% | -$264K | ﹤0.01% | 3004 |
|
|
2021
Q2 | $444K | Sell |
59,506
-33,142
| -36% | -$247K | ﹤0.01% | 2535 |
|
|
2021
Q1 | $723K | Buy |
92,648
+92,562
| +107,630% | +$722K | ﹤0.01% | 2468 |
|
|
2020
Q4 | $1K | Buy |
+86
| New | +$1K | ﹤0.01% | 3510 |
|
|
2020
Q3 | – | Sell |
-10,388
| Closed | -$68K | – | 3989 |
|
|
2020
Q2 | $68K | Buy |
+10,388
| New | +$68K | ﹤0.01% | 3285 |
|
|
2020
Q1 | – | Sell |
-20,317
| Closed | -$38K | – | 4000 |
|
|
2019
Q4 | $38K | Sell |
20,317
-784
| -4% | -$1.47K | ﹤0.01% | 3619 |
|
|
2019
Q3 | $30K | Sell |
21,101
-4,354
| -17% | -$6.19K | ﹤0.01% | 3794 |
|
|
2019
Q2 | $71K | Buy |
25,455
+21,960
| +628% | +$61.3K | ﹤0.01% | 3734 |
|
|
2019
Q1 | $16K | Buy |
+3,495
| New | +$16K | ﹤0.01% | 3954 |
|
|
2018
Q4 | – | Sell |
-2,724
| Closed | -$30K | – | 4485 |
|
|
2018
Q3 | $30K | Buy |
2,724
+2,192
| +412% | +$24.1K | ﹤0.01% | 3859 |
|
|
2018
Q2 | $9K | Buy |
+532
| New | +$9K | ﹤0.01% | 3928 |
|